Michael Ackermann's Net Worth
$38.3 Million
Who is Michael Ackermann?
Michael Ackermann has an estimated net worth of $38.3 Million. This is based on reported shares across multiple companies, which include Tarsus Pharmaceuticals, Inc., and Oyster Point Pharma, Inc..
SEC CIK
Michael Ackermann's CIK is 0001791249
Past Insider Trading and Trends
2021 was Michael Ackermann's most active year for acquiring shares with 4 total transactions. Michael Ackermann's most active month to acquire stocks was the month of May. 2021 was Michael Ackermann's most active year for disposing of shares, totalling 16 transactions. Michael Ackermann's most active month to dispose stocks was the month of July. 2022 saw Michael Ackermann paying a total of $1,350,000.00 for 123,257 shares, this is the most they've acquired in one year. In 2021 Michael Ackermann cashed out on 29,165 shares for a total of $752,386.60, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Tarsus Pharmaceuticals, Inc. (TARS) Snapshot price: $29.76
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 16
| |||
Form 4
| +0.35% | 4.26K |
—
|
—
| 1.21M |
Jun 15
| |||
Form 4
|
∞
| 100K |
$13.50 | $1,350,000.00 | 100K |
May 5
| |||
Form 4
| -0.48% | -5.83K |
$24.68 | -$143,934.45 | 1.2M |
Scheduled
|
Dec 1
| ||
Form 4
| -0.48% | -5.83K |
$27.82 | -$162,289.06 | 1.21M |
Scheduled
|
Nov 1
| ||
Form 4
| -0.46% | -5.63K |
$26.27 | -$147,999.61 | 1.22M |
Scheduled
|
Oct 12
| ||
Form 4
| -0.02% | -200.00 |
$25.03 | -$5,006.00 | 1.22M |
Scheduled
|
Oct 8
| ||
Form 4
| -0.48% | -5.83K |
$25.24 | -$147,236.59 | 1.22M |
Scheduled
|
Sep 1
| ||
Form 4
| -0.05% | -621.00 |
$25.15 | -$15,619.39 | 1.23M |
Scheduled
|
Aug 11
| ||
Form 4
| -0.31% | -3.83K |
$25.00 | -$95,725.00 | 1.23M |
Scheduled
|
Aug 6 - Aug 9
| ||
Form 4
| -0.11% | -1.38K |
$25.00 | -$34,576.50 | 1.23M |
Scheduled
|
Aug 5
| ||
Form 4
| +0.35% | 4.26K |
—
|
—
| 1.23M |
Jun 15
| |||
Form 4
| +5.42% | 63.19K |
—
|
—
| 1.23M |
Oct 20
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Oyster Point Pharma, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +10.78% | 14.8K |
—
|
—
| 152.16K |
Jun 8
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
∞
| 140.57K |
—
|
—
| 140.57K |
Nov 4
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||